Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the efficacy of metformin in abrogating androgen
deprivation therapy (ADT) induced insulin resistance as measured by homeostasis model
assessment (HOMAIR) in men with non-metastatic prostate cancer.